Qkine has appointed Thomas Scientific as a new US Distribution Partner, making it easier for stem cell scientists in the US to purchase the entire Qkine product portfolio.
Qkine is pleased to announce a new sales distribution agreement with industry-leading European distributor, CliniSciences.
Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus
Qkine is excited to be shortlisted for the Business Weekly Awards 2023 alongside scaling and inspirational companies in the Cambridge cluster.
Qkine partners with the UK’s new £12M cellular agriculture manufacturing hub, CARMA, to revolutionize sustainable food production
Qkine is delighted to extended its global reach by agreeing a new sales distribution agreement with Biogenuix, an Indian distribution partner.
Qkine is delighted to announce its collaboration with Sartorius, a global life science group, to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution.
On Friday, 28th April 2023, Qkine officially opened its new HQ at Murdoch House, Cambridge, UK. We were delighted to be joined by Mayor Dr. Nik Johnson, the Mayor of Cambridge & Peterborough, alongside our team, customers, investors, and representatives from the Cambridge ecosystem.
Qkine is excited to be a Top21.2023 winner in this year’s Cofinitive #21toWatch awards.
Qkine Ltd, a manufacturer of animal-free, highly bioactive, and innovative proteins and growth factors for life science applications, announces the close of its oversubscribed funding raise, having secured £4.3M.
© 2023 Qkine Ltd. Company number 10470662 registered in England and Wales. All rights reserved
